Beijing Konruns Pharmaceutical Co.,Ltd.

SSE:603590.SS

31.3 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Revenue 212.002179.087241.286203.666199.237199.976269.201285.73165.106278.736216.399215.4156.192213.181141.044244.502211.055258.619202.022277.07470.93304.69217.665350.822192.748326.224208.225304.078183.637200.846133.608
Cost of Revenue 20.9117.41626.32125.19622.45727.82525.73929.89517.5940.68231.24532.97121.2627.51223.32237.66217.26320.47615.43417.2246.11517.79712.33118.0989.43615.12610.05414.9879.87812.1699.221
Gross Profit 191.092161.671214.964178.47176.78172.151243.461255.834147.516238.054185.154182.429134.932185.669117.721206.841193.792238.143186.588259.84964.815286.893205.334332.724183.312311.099198.17289.09173.759188.677124.386
Gross Profit Ratio 0.9010.9030.8910.8760.8870.8610.9040.8950.8930.8540.8560.8470.8640.8710.8350.8460.9180.9210.9240.9380.9140.9420.9430.9480.9510.9540.9520.9510.9460.9390.931
Reseach & Development Expenses 8.07819.89611.74610.27811.3227.69226.93219.04321.24432.0719.05818.91916.72935.8312.35938.01216.06831.5424.24523.69713.62527.69129.2733.59918.22550.19913.5928.9247.53310.3846.629
General & Administrative Expenses 32.879-38.55267.931-4.81826.163-30.73256.083-6.40420.637-40.76359.746-6.50720.671-31.55349.104-3.30517.955-14.07416.08-4.82110.054-21.57410.585-4.6698.489-16.10611.208-5.46410.101-11.5056.338
Selling & Marketing Expenses 90.013-426.191169.341103.29790.45128.1124.951143.98675.549119.668116.517115.43371.535127.26247.637123.06493.321155.171116.396169.2732.313180.965136.735196.272123.232174.24123.543195.567109.547117.29172.616
SG&A 122.892-464.743161.758130.264116.61397.368181.033137.58296.18678.905176.263108.92692.20695.70896.742119.759111.276141.097132.476164.4542.367159.391147.32191.604131.721158.133134.751190.104119.649105.78678.954
Other Expenses 3.27711.831-77.523-0.2920-245.2182.449-2.448-0.58669.151-32.19723.280.03238.735-0.517-0-0.012-0.607-0.261-0.014-1.318-0.11-0.244-0.032-0.0350.0040.0680.201-0.00514.5260.001
Operating Expenses 134.24266.984171.496140.542128.076245.218176.028183.502116.843180.126163.124151.125108.967188.31377.159177.659128.107198.386153.579203.35445.435216.637164.977239.455145.863211.97149.298217.328129.816139.57386.558
Operating Income 56.852-105.31443.46837.92850.262-45.24267.88784.80535.83315.92327.71442.65954.40833.946.01539.25273.12850.32643.01479.72437.15972.38359.612112.04655.47120.64262.56169.97246.76953.43141.44
Operating Income Ratio 0.268-0.5880.180.1860.252-0.2260.2520.2970.2170.0570.1280.1980.3480.1590.3260.1610.3460.1950.2130.2880.5240.2380.2740.3190.2880.370.30.230.2550.2660.31
Total Other Income Expenses Net -1.302-0.035-0.86812.6130-19.799-0.0030.004-0.752-0.2540.101-0.174-0.06-2.909-0.114-00.184-0.607-0.261-0.014-1.318-0.11-0.244-0.043-0.0350.0040.0680.201-0.00514.5260.001
Income Before Tax 55.55-105.34942.651.10150.263-65.04167.88584.80935.08115.66927.81542.48554.34830.99245.49839.25173.11649.71942.75379.7135.84272.27459.368112.01455.435120.64662.62970.17346.76467.95741.441
Income Before Tax Ratio 0.262-0.5880.1770.2510.252-0.3250.2520.2970.2120.0560.1290.1970.3480.1450.3230.1610.3460.1920.2120.2880.5050.2370.2730.3190.2880.370.3010.2310.2550.3380.31
Income Tax Expense 7.413-3.3567.16510.1063.418-52.6538.4211.35.2176.2993.1023.1143.9085.8243.2463.6248.7218.1224.0518.8883.6089.8895.06911.7886.26513.6546.1939.9416.4949.7585
Net Income 44.497-70.75933.77337.54941.654-12.38855.74467.2225.6699.3721.63235.60146.43710.76837.19535.62764.39541.60138.70270.82332.23362.38454.299100.22649.171106.99256.43660.23240.2758.19936.44
Net Income Ratio 0.21-0.3950.140.1840.209-0.0620.2070.2350.1550.0340.10.1650.2970.0510.2640.1460.3050.1610.1920.2560.4540.2050.2490.2860.2550.3280.2710.1980.2190.290.273
EPS 0.28-0.4490.210.240.27-0.0790.360.430.160.060.140.230.30.0690.240.230.410.260.250.440.20.390.340.630.310.80.420.510.340.490.3
EPS Diluted 0.28-0.4490.210.240.27-0.0790.360.430.160.060.140.230.30.0690.240.230.410.260.250.440.20.390.340.630.310.80.420.510.340.490.3
EBITDA 57.486-103.56845.30862.18861.835-46.31279.67297.39147.32155.08838.3242.67254.55742.76456.09249.01881.5358.08650.35887.1219.3870.25667.82198.80164.31129.34848.87271.76346.39549.10437.828
EBITDA Ratio 0.271-0.5780.1880.3050.31-0.2320.2960.3410.2870.1980.1770.1980.3490.2010.3980.20.3860.2250.2490.3140.2730.2310.3120.2820.3340.3970.2350.2360.2530.2440.283